司帕生坦国内能买到吗?在哪能买到?
Sparsentan is an innovative drug used to treat primary immunoglobulin A nephropathy (IgAN), which can effectively reduce proteinuria levels. Since the drug has not yet been launched in mainland China, many patients have questions about where to purchase it and how to take it. This article will introduce in detail the purchase situation, legal acquisition methods and important medication precautions of sparsentan in China to help patients use this drug safely and rationally.
Is sparsentan available in China?
Currently, the drug market in mainland China has not been officially approved, which has caused some trouble to patients who need this drug treatment.
Domestic marketing situation
As of June 2025, sparsentan has not been approved by the China National Medical Products Administration, nor has it been officially marketed in China. Patients cannot purchase the drug through regular hospital pharmacies or chain pharmacies.
Medical insurance coverage
Since it is not listed in the country, Sparsentan is naturally not included in the national medical insurance catalog or the reimbursement scope of any commercial insurance. Patients need to purchase it entirely at their own expense, which is a considerable financial burden for patients who take medicine for a long time.
Alternatives
While waiting for domestic launch, patients can consider purchasing through legal cross-border channels, or discuss other alternative treatment options that have been approved in China with their attending doctors.
Although it is temporarily not available for direct purchase in China, obtaining sparsentan through formal cross-border channels is still a feasible option.
Where can I buy Sparsentan?
For patients who are in urgent need of Sparsentan treatment, it is important to understand the legal purchasing channels.
Cross-border medical service institutions
Some qualified cross-border medical institutions can provide spasentan purchase services. These institutions usually have cooperative relationships with overseas pharmacies and can assist patients in obtaining American original drugs or Laotian generic drugs, and provide complete cold chain transportation and customs clearance services.
Cross-border e-commerce platforms
Some e-commerce platforms that have obtained cross-border drug sales qualifications may also provide purchase services for sparsentan. When purchasing, you need to pay special attention to whether the platform has relevant qualifications and whether the drug provides complete source certificates and inspection reports.
Purchase directly overseas
Patients who are able to travel to the United States or Laos can purchase it with a prescription at local hospitals or pharmacies. The price of the original drug in the United States is about US$15,277 (400mg*30 tablets/box), and the price of the generic drug in Laos is about US$808/box.
No matter which purchase method you choose, you should ensure that the source of the medicine is formal and keep the complete purchase receipt and medicine packaging.
Precautions when using Sparsentan
As a prescription drug, Sparsentan requires special attention to the following matters when using it.
Dosage and usage
The recommended initial dose is 200 mg once a day, which can be increased to 400 mg once a day if tolerated well after 14 days. The tablet should be swallowed whole, preferably with water before breakfast or dinner. If you miss a dose, take the next dose as originally planned and do not take a double dose.
Adverse reaction monitoring
Common adverse reactions include peripheral edema, hypotension, dizziness, hyperkalemia and anemia. Blood pressure, blood potassium levels and liver function indicators need to be monitored regularly during medication. In particular, transaminase and bilirubin levels should be checked monthly during the 12 months before treatment.
Usage in special groups
It is prohibited for pregnant women, and women of childbearing age need to take reliable contraceptive measures; lactating women should suspend breastfeeding while taking the drug; elderly patients and those with liver and kidney dysfunction should use it with caution; the safety and effectiveness of children under 16 years of age have not yet been established.
If serious adverse reactions occur during medication, you should seek medical treatment immediately and consider adjusting the treatment plan. At the same time, care should be taken to avoid combination with multiple drugs, especially strong CYP3A inhibitors and strong inducers.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)